Status:
COMPLETED
Fatigue and Physical Performance During Pulmonary Rehabilitation
Lead Sponsor:
5 Santé
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-80 years
Brief Summary
Patients with COPD benefit from pulmonary rehabilitation (PR), but a ceiling effect of performance (ie. absence of additional exercise tolerance increase) is observed in 80% of patients from only 20 s...
Detailed Description
Exercise tolerance is an important predictor of health status in patients with chronic obstructive pulmonary disease (COPD). A reduced 6-min walking distance is associated with an increased mortality ...
Eligibility Criteria
Inclusion
- Patients admited for a 4-weeks inpatient pulmonary rehabilitation program
- With a confirmed diagnosis of COPD
Exclusion
- Severe or unstable heart disease
- Orthopedic, neurologic or psychatric comorbities
- Recent exacerbation (\<4 weeks)
Key Trial Info
Start Date :
February 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 9 2021
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04279730
Start Date
February 15 2020
End Date
April 9 2021
Last Update
November 14 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique du Souffle La Vallonie
Lodève, France, 34700
2
Clinique du Souffle La Solane
Osséja, France, 66340
3
Clinique du Souffle Les Clarines
Riom-ès-Montagnes, France, 15400